Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
The Journal of Dermatological Treatment|May 25, 2012
Clinical improvement and satisfaction with biologic therapy in patients with severe plaque psoriasis: results of a European cross-sectional observational studyEnno Christophers, Siegfried Segaert, Gary Milligan, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|March 8, 2011
Cost-effectiveness of treatment with etanercept for psoriasis in SwedenChristopher Knight, Josephine Mauskopf, Mats Ekelund, et al.
Tomography (Ann Arbor, Mich.)|October 26, 2022
Radiation Dose Reduction Opportunities in Vascular ImagingDavid Summerlin, Joseph Willis, Robert Boggs, et al.
Current Medical Research and Opinion|February 13, 2008
The effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthmaKevin Murphy, Harold Nelson, Bhash Parasuraman, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 26, 2008
Onset of effect of budesonide and formoterol administered via one pressurized metered-dose inhaler in patients with asthma previously treated with inhaled corticosteroidsHarold Kaiser, Bhash Parasuraman, Robert Boggs, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 6, 2008
Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhalerPaul Chervinsky, James Baker, George Bensch, et al.
Clinical Therapeutics|November 9, 2015
A Retrospective Administrative Claims Database Evaluation of the Utilization of Belimumab in US Managed Care SettingsXuehua Ke, Debra F Eisenberg Lawrence, Alan Oglesby, et al.
Clinical and Experimental Rheumatology|December 24, 2014
Early treatment of psoriatic arthritis is associated with improved patient-reported outcomes: findings from the etanercept PRESTA trialBruce Kirkham, Kurt de Vlam, Wenzhi Li, et al.
BMJ Open Diabetes Research & Care|February 1, 2022
Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UKTracey Weiss, Lingfeng Yang, Richard D Carr, et al.
Patient Preference and Adherence|December 4, 2020
Real-World Adherence and Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists Therapy in Type 2 Diabetes Mellitus Patients in the United StatesTracey Weiss, Richard D Carr, Sampriti Pal, et al.
Pageof 2